PATENT CLAIM ANALYSIS

Application Number: 16174954
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "562000"]

Abstract:
Pharmaceutical compositions are described herein, the compositions consisting essentially of anhydrous suspensions of therapeutically effective quantity of a pharmaceutically acceptable reducing agent capable of undergoing thiol-disulfide exchange with cystine to form a mixed disulfide (such as tiopronin). In some embodiments, the suspension also contains one or more urine alkanizing agent(s). Methods for fabricating the compositions and using them are also described.

Claim (Index 1):
A pharmaceutical composition formulated as an anhydrous suspension comprising:\n (a) a dispersed phase comprising a therapeutically effective quantity of a pharmaceutically acceptable reducing agent capable of undergoing thiol-disulfide exchange with cystine to form a mixed disulfide; (b) at least one pharmaceutically acceptable surfactant or solubilizing and suspending agent; and (c) an anhydrous dispersion medium, wherein the dispersed phase is dispersed within the dispersion medium.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 97.0
- Lexical Diversity: 1.31481
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15644286', '14808777', '14808847', '14808809', '14808871']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7174599838551212
- 35 USC 102 Novelty (BERT): 0.4960103902706635
- Combined Prediction Score: 0.6953150244966755
- Mean Citation Score: 145.37784000000005
- Max Citation Score: 148.26672
- Similarity Product: 86.50774952201843

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test